Mergers & Acquisitions

Procyon's shareholders approve merger via acquisition with Cellpep S.A

Published in Cancer Weekly, March 28th, 2006

Procyon Biopharma Inc. (PBP) announced that at its special meeting of shareholders, shareholders of Procyon approved the acquisition of Cellpep S.A. and the concurrent $18.1 million private placement of special warrants and units.

The name change of Procyon Biopharma Inc. to Ambrilia Biopharma Inc. and the future share consolidation were also approved by Procyon' shareholders.

Following the closing of the acquisition and concurrent financing, the name of Procyon Biopharma Inc. will be changed to Ambrilia Biopharma Inc. and its shares will continue to trade on the Toronto Stock Exchange under the new ticker symbol AMB.

Procyon...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2006-03-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry